An adenosine A2A receptor gene haplotype is associated with migraine with aura

Cephalalgia

Volumn 27, Issue 2, 2007, Pages 177-181

  Hohoff, C ^a   Marziniak, M ^b,c   Lesch, K P ^b   Deckert, J ^a   Sommer, C ^b   Mossner R ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Adenosine A2A receptor; Association study; Haplotype; Migraine with aura; Polymorphisms

Indexed keywords

ADENOSINE A2A RECEPTOR; CAFFEINE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FREQUENCY ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PATHOPHYSIOLOGY; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MIGRAINE WITH AURA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, ADENOSINE A2A;

EID: 33846542582     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01254.x     Document Type: Article

References (18)

1. Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet 2004; 114:225-35.
2. Goadsby PJ, Kullmann DM. Another migraine gene. Lancet 2005; 366:345-6.
3. Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE. A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 2002; 125:1392-401.
4. Sebastiao AM, Ribeiro JA. Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 2000; 21:341-6.
5. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754-62.
6. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2005; 25:776-87.
7. Marziniak M, Mössner R, Schmitt A, Lesch KP, Sommer C. A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005; 64:157-9.
8. 2A gene to the development of disease. Mol Psychiatry 1998; 3:81-5.
9. 2A receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003; 28:1694-702.
10. Barrett JC, Fry B, Maller J, Daly MJ. Haploview. analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5.
11. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 1999; 45:242-6.
12. Sebastiao AM, Macedo MP, Ribeiro JA. Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br J Pharmacol 2000; 129:374-80.
13. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117:199-210.
14. Magistretti PJ, Cardinaux JR, Martin JL. VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling. Ann NY Acad Sci 1998; 865:213-25.
15. Kern RZ, Asa S. Left atrial myxoma presenting as migraine with aura: a VIP-induced syndrome? Headache 2005; 45:251-4.
16. 2A receptor and panic disorder. Neuropsychopharmacology 2004; 29:558-65.
17. 2A receptor. Nature 1997; 388:674-8.
18. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005; 18:305-10.